Angiotensin-converting enzyme DD genotype is associated with worse perinatal cardiorespiratory adaptation in preterm infants

Journal of Pediatrics

Volumn 143, Issue 6, 2003, Pages 746-749

  Harding, David ^a   Dhamrait, Sukhbir ^b   Marlow, Neil ^b   Whitelaw, Andrew ^b   Gupta, Sanjay ^b   Humphries, Steve ^b   Montgomery, Hugh ^b  

^a ST MICHAEL'S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADAPTATION; ARTICLE; CARDIOPULMONARY INSUFFICIENCY; CONTROLLED STUDY; FEMALE; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0344233247     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0022-3476(03)00582-1     Document Type: Article

References (22)

1. Mattioli L, Zakheim RM, Mullis K, Molteni A. Angiotensin-1-converting enzyme activity in idiopathic respiratory distress syndrome of the newborn infant and in experimental alveolar hypoxia in mice. J Pediatr 1975;87:97-101.
2. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, et al. Angiotensin converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995;92:1387-8.
3. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin-1 converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993;290:33-40.
4. Williams AG, Rayson MP, Jubb M, World M, Woods DR, Hayward M, et.al. The ACE gene and muscle performance. Nature 2000;403:614.
5. Montgomery HE, Clarkson P, Dollery CM, Prasad K, Losi MA, Hemingway H, et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997;96:741-7.
6. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002;166:646-50.
7. Boldt J, Menges T, Wollbruck M, Harter K, Hempelmann G. Continuous i.v. administration of the angiotensin-converting enzyme inhibitor enalaprilat in the critically ill: effects on regulators of circulatory homeostasis. J Cardiovasc Pharmacol 1995;25:416-23.
8. Guba M, Steinbauer M, Buchner M, Frolich D, Farkas S, Jauch KW, et al. Differential effects of short-term ACE-and AT1-receptor inhibition on postischaemic injury and leukocyte adherence in vivo and in vitro. Shock 2000;13:190-6.
9. Brull DJ, Sanders J, Rumley A, Lowe GD, Humphries SE, Montgomery HE. Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release. Heart 2002;87:252-5.
10. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin-1-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
11. Investigators for the Avon Premature Infant Project. Randomised trial of parental support for families with very preterm children. Arch Dis Child Fetal Neonatal Ed 1998;79:F4-11.
12. Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T, et al. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med 1994;87:211-4.
13. O'Dell SD, Humphries SE, Day IN. Rapid methods for population-scale analysis for gene polymorphisms: the ACE gene as an example. Br Heart J 1995;73:368-71.
14. Harding D, Haines PB, Brull D, Vassiliou V, Ellis I, Hart A, et al. Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism. Am J Respir Crit Care Med 2002;165:1103-6.
15. Marshall JC. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 2001;29:S99-106.
16. Kennedy BC, Hall GM. Neuroendocrine and inflammatory aspects of surgery: do they affect outcome? Acta Anaesthesiol Belg 1999;50: 205-9.
17. Woods DR, Pollard AJ, Collier DJ, Jamshidi Y, Vassiliou V, Hawe E, et al. Insertion/deletion polymorphism of the angiotensin 1-converting enzyme gene and arterial oxygen saturation at high altitude. Am J Respir Crit Care Med 2002;166:362-6.
18. Jauch KW, Hartl WH, Georgieff M, Wolfe RR, Dietze GJ, Gunther B. Low-dose bradykinin infusion reduces endogenous glucose production in surgical patients. Metabolism 1998;37:185-90.
19. Wicklmayr M, Dietze G, Gunther B, Schifmann R, Bottger I, Geiger R, et al. The kallikrein-kinin system and muscle metabolism - clinical aspects. Agents Actions 1980;10:339-43.
20. DeWitt LM, Putney JW Jr. Stimulation of glycogenolysis in hepatocytes by angiotensin II may involve both calcium release and calcium influx. FEBS Lett 1983;160:259-63.
21. Reisenleiter F, Katz N, Gardemann A. Control of hepatic carbohydrate metabolism and haemodynamics in perfused rat liver by arterial and portal angiotensin II. Eur J Gastroenterol Hepatol 1996;8:279-86.
22. Messerli FH, Nowaczynski W, Honda M, Genest J, Boucher R, Kuchel O, et al. Effects of angiotensin II on steroid metabolism and hepatic blood flow in man. Circ Res 1977;40:204-7.